ALEXANDRIA, Va. -- Like other viral illnesses, SARS coronavirus infection can present with only mild symptoms, according to a study published in the Feb. 15, 2004 issue of The Journal of Infectious Diseases, online now. The findings help to flesh out the clinical portrait of this novel illness, which emerged in 2003 as a syndrome in which fever and mylagia progressed rapidly to pneumonia and respiratory distress, prompting its initial designation of SARS, or severe acute respiratory syndrome. One implication of the current study is that early detection of future SARS-associated coronavirus outbreaks will require attention to the mild end of the disease's spectrum.
The study, reported by Khek-Yu Ho, PA, Tambyah, and coworkers in Singapore, involved 372 healthcare workers at a large teaching hospital where 21 patients with SARS (including five of the hospital's staff) were treated. A questionnaire was used to determine which workers had had direct contact with SARS patients, which had no direct contact but were exposed, and which were not exposed. Subjects provided serum samples at the time of possible SARS exposure and a median of 31 days later; the samples were then screened for SARS antibodies using an enzyme-linked immunosorbent assay or a dot-blot immunoassay, and those with positive results were confirmed by an indirect immunofluorescence assay and a virus neutralization assay.
The investigators reported that none of the 260 hospital workers classified as not exposed was seropositive for the virus. Of 112 classified as exposed, eight were seropositive. Four of the eight had had direct contact with SARS-infected patients; the others had been in wards where SARS patients had been before transfer to a SARS facility. All eight had fever, but only six also had radiographic evidence of pneumonia and thus met clinical criteria for SARS. Symptoms in the two mildly infected subjects included chills and myalgia or cough, all of which resolved within three days of symptomatic therapy.
Noting that the vast majority of SARS cases thus far reported have occurred in hospitals, the Singapore investigators characterized their study as the first to demonstrate the infection in health care workers with normal chest X-rays. They pointed out that both clinical SARS and milder illness developed in those who were exposed to but not in direct contact with infected patients, suggesting that infection can occur regardless of the intensity of exposure. On the other hand, there was no disease transmission involving health care workers who were in other areas of the hospital. Moreover, no secondary transmission involving the two subjects with mild disease was seen. The investigators cautioned that although mildly symptomatic cases may reflect transmission of low viral loads that are unlikely to spark epidemics, such cases may remain "below the radar" if not actively sought with sensitive assays.
Source: Infectious Diseases Society of America
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.